LastChange / % ChangeVolumeAvg Volume (10 day)Morningstar CategoryAsset Class
167.82 -0.17   -0.10%7.4M9.6MCommodities Precious MetalsCommodities

Delayed by at least 15 minutes 11/9/2012 4:00 PM | For standardized performance data click on the Performance tab below.
Market is closed. As of 04:00 PM ET 11/9/2012
Strategy for SPDR Gold Shares Trust
The investment seeks to replicate the performance, net of expenses, of the price of gold bullion. The trust holds gold, and is expected to issue baskets in exchange for deposits of gold, and to distribute gold in connection with redemption of baskets. The gold held by the trust will only be sold on an as-needed basis to pay trust expenses, in the event the trust terminates and liquidates its assets, or as otherwise required by law or regulation.
Bid/Size
-- / --
Ask/Size
-- / --
Price Open
168.21
Previous Close
167.99
52wk High/Date
174.81 / 11/9/2011
52wk Low/Date
148.27 / 12/29/2011
Today's Range
167.55 - 168.54
Market Capitalization
74.4B
Total Net Assets/Date
73.8B / 10/31/2012
Net Asset Value/Date
166.37 / 11/8/2012
Gross Expense Ratio
0.40
Net Expense Ratio
0.40
Declared -- Div
0.00 / --
Distribution Yield (TTM)
0.00
Ex-Date
--
Date of Record
--
Payable
--
Payable Date
--
Inception Date
11/18/2004
SEC 30 Day Yield
--
Last Trade as of 11/9/2012 4:00 PM ET

Morningstar rates funds from one to five stars based on how well they've performed (after adjusting for risk and accounting for all sales charges) in comparison to similar funds. Within each Morningstar Category, the top 10% of funds receive five stars, the next 22.5% four stars, the middle 35% three stars, the next 22.5% two stars, and the bottom 10% receive one star. Funds are rated for up to three time periods--three-, five-, and 10 years--and these ratings are combined to produce an overall rating. Funds with less than three years of history are not rated. Ratings are objective, based entirely on a mathematical evaluation of past performance. They're a useful tool for identifying funds worthy of further research, but shouldn't be considered buy or sell recommendations.